Sulfasalazine Alternatives Compared
Sulfasalazine | Otezla (apremilast) | Stelara (ustekinumab) |
|
---|
Sulfasalazine | Otezla (apremilast) | Stelara (ustekinumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Alopecia, Crohn's Disease, Crohn's Disease - Maintenance, Juvenile Rheumatoid Arthritis, Lymphocytic Colitis, Crohn's Disease - Active, Inflammatory Bowel Disease, Psoriatic Arthritis... View more |
Prescription only
Otezla is a PDE4 inhibitor that may be used to treat adults with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. It may also be used to treat plaque psoriasis... View more |
Prescription only
Stelara is an immunosuppressant medication that works by binding to two inflammatory cytokines, IL-12 and IL-23, which have been identified as important contributors to chronic inflammation. Stelara... View more |
Related suggestions |
|||||||||||||||||||||||
More about Sulfasalazine | More about Otezla (apremilast) | More about Stelara (ustekinumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Sulfasalazine has an average rating of 6.1 out of 10 from a total of 198 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 32% reported a negative effect. |
Otezla has an average rating of 5.2 out of 10 from a total of 439 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 40% reported a negative effect. |
Stelara has an average rating of 7.7 out of 10 from a total of 250 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Sulfasalazine prices |
View all Otezla prices |
View all Stelara prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Azulfidine, Azulfidine EN-tabs |
N/A |
Other ustekinumab brands include: Imuldosa, Otulfi, Pyzchiva, Selarsdi, Steqeyma, Wezlana, Yesintek | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
10 hours |
9 hours |
1291.2 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 264 drugs are known to interact with Sulfasalazine:
|
A total of 103 drugs are known to interact with Otezla:
|
A total of 529 drugs are known to interact with Stelara:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 20, 1950 |
March 21, 2014 |
September 25, 2009 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.